Pediatrics Strabismus News

Vyluma Inc. has announced that the FDA will review its new drug application for NVK002, a preservative-free, low-dose atropine eye drop for myopia in children aged 3 to 17 years.

VILAMOURA, Portugal — At the ESCRS winter meeting, Serge Resnikoff, MD, PhD, chair of the International Myopia Institute, discusses myopia, an issue that cuts across all subspecialties in ophthalmology.

VILAMOURA, Portugal — At the ESCRS winter meeting, Marie-José Tassignon, MD, PhD, speaks about the challenges of pediatric cataract surgery.

VILAMOURA, Portugal — At the ESCRS winter meeting, Paolo Nucci, MD, addressed the hot topic of myopia control. Myopia progression can be slowed down, he said, but consensus on treatment options and optimization has not been reached.

The prevalence of diabetic retinopathy among children and adolescents with type 2 diabetes greatly increases 5 years after diabetes diagnosis, according to findings from a systematic review and meta-analysis.

Prenatal maternal factors such as socioeconomic status, smoking and chorioamnionitis were found in a study to be associated with the risk for retinopathy of prematurity in preterm infants.

We read, with great concern, the recent article regarding workforce challenges in pediatric ophthalmology (Healio/Ocular Surgery News, Jan. 25, 2023, page 1).

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2023, Yoshihiro Yonekawa, MD, discusses nomenclature updates for retinopathy of prematurity and retinal surgery in pediatric patients.

KOLOA, Hawaii — In this Healio Video Perspective from Retina 2023, Yoshihiro Yonekawa, MD, discusses nomenclature updates for retinopathy of prematurity and retinal surgery in pediatric patients.

KOLOA, Hawaii — Gonioscopy-assisted transluminal trabeculotomy has shown positive results for the treatment of myocilin glaucoma, according to a presenter here.